Trial intelligence / Profile preview

Observation vs Radiation for Pelvic Lymphocysts in Cervical Cancer

NCT03071289Phase 3Unknown

Sponsor
Sun Yat-sen University
Start
Jun 2017
Primary completion
Mar 2025
Countries
1
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: 5-year local-recurrence-free survival. Status: unknown.

Beyond the preview

Go deeper on NCT03071289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03071289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call